LumiraDX Closes SPAC Merger, Begins Trading on Nasdaq

lumiraDx

Diagnostic testing company LumiraDx and CA Healthcare Acquisition completed their merger. LumiraDx shares begin trading today on the Nasdaq under LMDX. Warrants list under LMDXW. The company listed at a valuation of $3 billion. Read more.

Total
0
Shares
Related Posts